tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

CYCC Stock Latest News

Cyclacel Pharmaceuticals Announces Participation at the H.C. Wainwright 26th Annual Global Investment Conference
Press ReleasesCyclacel Pharmaceuticals Announces Participation at the H.C. Wainwright 26th Annual Global Investment Conference
16d ago
CYCC
Cyclacel Pharmaceuticals confirms filing of appeal to Nasdaq delisting letter
PremiumThe Fly
Cyclacel Pharmaceuticals confirms filing of appeal to Nasdaq delisting letter
17d ago
CYCC
Cyclacel Pharmaceuticals Confirms It Has Filed an Appeal to Nasdaq Staff Delisting Letter
PremiumPress Releases
Cyclacel Pharmaceuticals Confirms It Has Filed an Appeal to Nasdaq Staff Delisting Letter
17d ago
CYCC
Eleven option delistings on August 19th
PremiumThe Fly
Eleven option delistings on August 19th
1M ago
ASMB
BPTH
Cyclacel Pharmaceuticals reports Q2 EPS (72c), consensus ($1.43)
PremiumThe Fly
Cyclacel Pharmaceuticals reports Q2 EPS (72c), consensus ($1.43)
1M ago
CYCC
Cyclacel Pharmaceuticals Reports Second Quarter Financial Results and Provides Business Update
PremiumPress ReleasesCyclacel Pharmaceuticals Reports Second Quarter Financial Results and Provides Business Update
1M ago
CYCC
Cyclacel Pharmaceuticals to Release Second Quarter 2024 Financial Results
Premium
Press Releases
Cyclacel Pharmaceuticals to Release Second Quarter 2024 Financial Results
1M ago
CYCC
Cyclacel Pharmaceuticals (CYCC) Q2 Earnings Cheat Sheet
Premium
Pre-Earnings
Cyclacel Pharmaceuticals (CYCC) Q2 Earnings Cheat Sheet
2M ago
CYCC
Cyclacel Announces Notice of Intention to Grant New European Patent Covering Plogosertib Pharmaceutical Compositions
PremiumPress Releases
Cyclacel Announces Notice of Intention to Grant New European Patent Covering Plogosertib Pharmaceutical Compositions
3M ago
CYCC
Cyclacel Pharmaceuticals receives notice of intention to grant European patent
PremiumThe Fly
Cyclacel Pharmaceuticals receives notice of intention to grant European patent
3M ago
CYCC
Cyclacel Pharmaceuticals Announces Key Corporate Decisions at 2024 Annual Meeting
PremiumCompany Announcements
Cyclacel Pharmaceuticals Announces Key Corporate Decisions at 2024 Annual Meeting
3M ago
8K
CYCC
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
4M ago
EQ
AFMD
Biotech Alert: Searches spiking for these stocks today
PremiumThe FlyBiotech Alert: Searches spiking for these stocks today
4M ago
AFMD
BPTH
Cyclacel Pharmaceuticals announces presentation of data on fadraciclib
Premium
The Fly
Cyclacel Pharmaceuticals announces presentation of data on fadraciclib
4M ago
CYCC
Cyclacel’s Fadraciclib Demonstrates Efficacy in Patient-Derived Colorectal Cancer Models at the 2024 ASCO Annual Meeting
Premium
Press Releases
Cyclacel’s Fadraciclib Demonstrates Efficacy in Patient-Derived Colorectal Cancer Models at the 2024 ASCO Annual Meeting
4M ago
CYCC
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
4M ago
ACIU
ADAP
Cyclacel: Data from fadraciclib monotherapy studies support ongoing POC study
PremiumThe Fly
Cyclacel: Data from fadraciclib monotherapy studies support ongoing POC study
4M ago
CYCC
Cyclacel Pharmaceuticals reports Q1 EPS ($2.27), consensus ($4.74)
PremiumThe Fly
Cyclacel Pharmaceuticals reports Q1 EPS ($2.27), consensus ($4.74)
4M ago
CYCC
Cyclacel Pharmaceuticals to Release First Quarter 2024 Financial Results
PremiumPress Releases
Cyclacel Pharmaceuticals to Release First Quarter 2024 Financial Results
4M ago
CYCC
Cyclacel Pharmaceuticals files to sell 15.2M shares of common stock for holders
PremiumThe FlyCyclacel Pharmaceuticals files to sell 15.2M shares of common stock for holders
5M ago
CYCC
CYCC Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Premium
Pre-Earnings
CYCC Earnings Report this Week: Is It a Buy, Ahead of Earnings?
5M ago
CYCC
Biotech Alert: Searches spiking for these stocks today
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
5M ago
EBS
AMRN

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >